RYBREVANT FASPRO™ Receives FDA Approval for First-Line EGFR-Mutated NSCLC
December 26, 2025
Brand Name :
Oxytrol
(United States) [Available]Synonyms :
Class :
Anticholinergic and Urinary antispasmodics
Dosage Forms & Strengths
Tablet
5mg
Tablet-ER
5mg
10mg
15mg
Syrup
5mg/5ml
Dosage Forms & Strengths:
Tablet
5mg
Tablet-ER
5mg
10mg
15mg
Syrup
5mg/5ml
When encainide is used together with oxybutynin, this leads to a reduction in the encainide’s metabolism
Adverse drug reactions:
Frequency Defined
>10%
Dry mouth
Somnolence
Nausea
1-10%
Dry eyes
Diarrhea
Asthenia
Dizziness
Headache
Pain
Rhinitis
Blurred vision
Nausea
<1%
Dysphagia
Frequent bowel movements
Chest discomfort
Thirst
Anorexia
Fluid retention
Hot flush
Dysphonia
Frequency Not Defined
Cycloplegia
Memory impairment
Mydriasis
Tachycardia
Impairment of mental alertness
Pregnancy warnings:
Pregnancy category: N/A
Breastfeeding warnings:
The release of the drug into the human breastmilk is unknown
Pregnancy Categories:
Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester.
Category B: No evidence shown of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women
Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a result in humans must take care of potential risks in pregnant women
Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits
Category X: Drugs listed in this category outweigh risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Patient Information Leaflet
Generic Name: oxybutynin
Pronunciation: OX-i-BUE-ti-nin
Why do we use oxybutynin?
oxybutynin belongs to the class of anticholinergic agents used to treat muscle spasms of the bladder, overactive bladder, and Detrusor Overactivity in pediatrics